GRML
****Sponsored by Primetime Profiles LLC on behalf of Greenland Mines LTD
$30 Million has been invested in theSkaergaard Project since 2000 --One of the largest undeveloped precious metals deposits on the planet — sitting in a U.S.-aligned jurisdiction, independently verified, and trading for fractions of a penny on the dollar
Greenland Mines Reports Up To 45% - 55% Increase in Palladium Equivalent (PdEq) Grades at Skaergaard in Sensitivity Study $68 Billion
in the Ground $48 Million Market Cap
Read The Investor Presentation HERE
Hello Everyone,
Yesterday's profile opened at .62 and it exploded all the way to .74. Greenland Mines (Nasdaq: GRML) is not a speculative exploration play.The gold, palladium, and platinum at its Skaergaard Project in southeast Greenland have already been confirmed through an independent NI 43-101 Technical Report by SLR Consulting. The deposit is known. The metals are there. What the market hasn't caught up to yet is the sheer scale of what's sitting in the ground.
At February 2026 metal prices, the Skaergaard deposit contains an estimated $68 billion worth of metals in the ground. The entire company is valued at roughly $48.5 million. That gap is the story.
GRML bottomed out near $0.21 per share in mid-February 2026 and has since roughly doubled, trading in the $0.38–$0.42 range as of today. Volume has picked up sharply, with multiple sessions logging multi-million share days. An independent analysis released earlier this month added fuel to the move — showing that effective metal values at the site are 45–55% higher than what the 2022 resource estimate assumed, simply because gold, palladium, and platinum prices have all moved significantly since then.
What the Deposit Actually Holds
- 6.83 million ounces of gold — a meaningful standalone asset at today's prices, sitting in a politically stable, NATO-aligned territory less than 1,600 km from the U.S. East Coast.
- 17.15 million ounces of palladium — enough to satisfy 13 to 15 years of total U.S. consumption, according to the company. Right now, 75–80% of global palladium supply comes from Russia and South Africa.
- 1.37 million ounces of platinum — another metal classified as critical by the U.S. Geological Survey, with supply similarly concentrated in geopolitically sensitive regions.
Greenland Is a U.S. Strategic Priority
The policy conversation around Greenland has moved well past theory. As a self-governing territory of Denmark and a longtime U.S. ally, Greenland sits in a uniquely advantageous position — stable, friendly, close, and resource-rich. Palladium and platinum both appear on the USGS Critical Minerals List, and securing domestic or allied-nation supply of these metals is now a stated federal policy objective.
Palladium is not just an industrial metal. It's used in missile guidance systems, radar arrays, satellite components, and secure communications infrastructure. Dependence on Russia and South Africa for 75–80% of global supply is a vulnerability the U.S. government has been trying to address for years. A massive, independently verified palladium deposit controlled by an American-listed company in a friendly jurisdiction is exactly what that policy framework is looking for.
Americans have a strong case for being bullish on Greenland because of its geostrategic position, which is arguably one of the most valuable on the planet. Greenland sits at the crossroads of North America, Europe, and the Arctic, effectively acting as a gatekeeper to the North Atlantic and emerging Arctic shipping lanes. As polar ice continues to recede, new maritime routes are opening that could reshape global trade, and Greenland is positioned right along those corridors. From a defense standpoint, it anchors the critical Greenland–Iceland–UK (GIUK) gap, a choke point used to monitor naval activity—especially from Russia—making it indispensable for U.S. and NATO security architecture. It also hosts infrastructure key to missile warning and space surveillance, reinforcing homeland defense in an era of increasingly advanced threats.
Beyond military relevance, Greenland represents a long-term economic and technological opportunity tied to the future of energy and supply chains. The island holds significant deposits of rare earth minerals and other critical resources used in everything from semiconductors to electric vehicles and renewable energy systems. As the U.S. looks to reduce dependence on foreign suppliers—particularly China—Greenland could become part of a more secure, Western-aligned resource base. At the same time, its cold climate and geographic isolation make it attractive for next-generation infrastructure like data centers and advanced computing facilities. While extraction and development remain difficult today, the strategic value lies in the optionality: as technology improves and the Arctic becomes more accessible, Greenland’s importance is likely to increase rather than diminish.
Greenland sits at the intersection of defense, trade, energy, and emerging technologies, and in a world defined by great-power competition and resource security, that combination is rare.
What is truly encouraging is that Greenland is already home to the production of Tens of thousands of ounces of gold annually.
Just over a month ago we saw Klotho Neurosciences rebrand and focus on a 2 pronged approach with the acquisition of Greenland Mines Corp who owns 80% of one of the largest and most significant undeveloped palladium, gold, and platinum deposits in the world.
What They Actually Control
Greenland Mines holds an 80% stake in the Skaergaard Project, with an option to acquire the remaining 20%. The deposit itself has been studied for nearly 90 years — first discovered in 1935, with a major gold-and-palladium discovery following in 1986. Researchers from institutions including Aarhus University, Caltech, and the Geological Survey of Denmark and Greenland have spent decades documenting its structure.
The company is now advancing into the next phase. They've engaged WSP Denmark to conduct environmental baseline work, secured an icebreaker vessel for their 2026 field season, and are working toward a Preliminary Economic Assessment. Separately, they've outlined plans for a drilling program targeting a doubling of the total resource to approximately 50 million contained ounces across gold, palladium, and platinum — with vanadium and gallium potentially added to the mix.
Located in Southeast Greenland, the Skaergaard Project is one of the largest undeveloped gold (Au), palladium (Pd), and platinum (Pt) deposits in the world, with a total in-situ resource value of approximately $68 Billion1 at February 2026 metal prices.
Through a new drilling and development program, Greenland Mines Ltd aims to double its resource to ~50 million contained ounces of Au, Pd, and Pt, as well as adding vanadium and gallium to its raw critical metals portfolio.
The Skaergaard intrusion is recognized as one of the world's largest undeveloped resources of gold‑palladium‑platinum, with additional metals that are increasingly important to energy transition, defense application and high‑technology supply chains.
While the project area has benefitted from decades of geological, resource and academic work, historical environmental datasets are relatively limited, making the current, large‑scale baseline program a critical enabler for responsible, long‑life mine development.
NEWS
The 5 Strategic Projects Quietly Defining the Next Decade of West's Critical Minerals Supply
5 days ago
Newmont Transaction Highlights Rising Valuations For Undeveloped Gold Assets
5 days ago
5 days ago
95% Of U.S. Palladium Is Imported. 17 Million Ounces of It Sit in One Greenland Deposit
6 days ago
6 days ago
May 7, 2026
May 7, 2026
May 7, 2026
May 7, 2026
May 6, 2026
MANAGEMENT
Dr. Joseph SinkuleFounder, Chief Executive Officer (CEO), Director and Chairman of the Board
Dr. Sinkule is the company’s Chief Executive Officer (CEO), Founder, and the Chairman of the Board of Directors. He has over 40 years of drug, biologic, and medical device R&D and commercialization experience. This serial entrepreneur is the founder and driving force behind the Company, its growing product portfolio, and its financing strategies. He has personally managed over 8 drug and biotech products successfully through FDA approval to market, 5 medical devices and 8 in vitro diagnostics. He has hired and managed both small and large teams of experienced people in pharma and biotech organizations, and managed contract research organizations (“CROs”) and contract development and manufacturing companies (“CDMOs”), working for large and small clients. After serving in academics and then in industry, Dr. Sinkule has evolved into a successful businessman and entrepreneur. He serves on the Board of two companies, and routinely consults for venture capitalist firms, investment banks, as well as both large and early-stage pharmaceutical and biotech companies.
Mr. Jeffrey LeBlancChief Financial Officer
Mr. LeBlanc has over 20 years of experience in managing financial operations, investing, advising Fortune 500 companies, and launching new ventures. He is the co-founder of Winvest Acquisition Corp. (Ticker: WINV), a special purpose acquisition company. Prior to Winvest, Mr. LeBlanc launched Out of Print, a direct-to-consumer merchandise platform that was acquired by Penguin Random House in 2017. He previously served in investment roles at Greenlight Capital and GE Capital, and started his career at McKinsey and Co. Mr. LeBlanc previously served on the Boards of Riot New Media Group and Books For Africa. He received an MBA from Harvard Business School and a BS in Chemical Engineering from MIT.
Bo Møller StensgaardPresident
Bo is a seasoned executive with over 20 years in mineral exploration and natural resource development across Europe and the Arctic, starting in Greenland geology in 1998. Holding a PhD in economic geology and former Senior Research Scientist at the Geological Survey of Danmark and Greenland, he has led listed and private resource companies, advancing projects from early exploration to exploitation through technical studies, environmental/social impact assessments, permitting, and stakeholder engagement. His expertise includes listed-company leadership, international investor relations, building expert teams, and leveraging extensive networks in business, academia, politics, and the European raw materials ecosystem – gained partly from his senior advisory role at EIT RawMaterials advising on EU policy and funding. This positions him as a strong leader for Greenland Mines Corp, providing credible access to North American and European capital markets and strategic partners.
Dr. Miguel Chillón RodriguezChief Scientific Officer and Consultant
Professor Dr. Chillon is the inventor of the α-Klotho patents and technology know how. He has over 25 years of research experience in several key areas of α-klotho and adeno-associated virus (“AAV”) packaging and gene delivery. Miguel has several associates that work with him to expedite development and further the intellectual properties and scientific publications. He leads the research group on Gene therapy for CNS diseases at Universitat Autonoma De Barcelona and Institucio Catalana De Recerca I Estudis Avancats. Miguel is also the Director of the Viral Vector Production Unit at Vall d’Hebrón Hospital, and serves Chair of the ATMP Platform of European Infrastructure for Translational Medicine
Dr. Shalom HirshmanMedical Advisor and Director
Dr. Shalom Hirschman, M.D. is a preeminent research physician, a clinical medical expert, and entrepreneur in infectious diseases, oncology, and cancer supportive care. He is a key consulting advisor to the Company. As a young man, he served as an intern and resident in medicine at the Massachusetts General Hospital and Harvard Medical School, and then went on to a career in molecular biology and virology research at the National Institute of Health (NIH). During his career in medical research, he interacted closely with several Nobel Prize winners including Drs. Berson and Yalow (Nobel Prize for development of radioimmunoassays). He was recruited to The Mount Sinai School of Medicine and The Mount Sinai Hospital in New York City as Head of the Department of Infectious Diseases, and eventually he also became Vice-Chairman and Chairman of the Department of Medicine at Mount Sinai, where he remained for three decades. He still is asked to consult on difficult diagnostic dilemmas like the recent COVID-19 pandemic.
Sincerely,
DISCLAIMER
THIS WEBSITE/NEWSLETTER IS A PUBLICATION OF ONE22 MEDIA, LLC, HEREIN REFERRED TO AS O22. O22’S REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATIONAL PURPOSES ONLY.O22 IS ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION.
O22 HAS BEEN COMPENSATED A FEE OF TWENTY THOUSAND USD BY A THIRD PARTY, PRIMETIME PROFILES, LLC FOR A ONE DAY GRML PROFILE ON 5/18/26. O22 HAS PREVIOUSLY BEEN COMPENSATED A FEE OF FIFTEEN THOUSAND USD BY A THIRD PARTY, PRIMETIME PROFILES, LLC FOR A ONE DAY GRML PROFILE ON 4/14/26.
BY SUBSCRIBING TO OR OTHERWISE USING THIS WEBSITE/NEWSLETTER, YOU AGREE TO HOLD O22 AND ITS OPERATORS, OWNERS, AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS, DAMAGE, OR INJURY THAT YOU MAY INCUR, MONETARY OR OTHERWISE.
INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AN EXTREMELY HIGH DEGREE OF RISK. NEVER INVEST IN ANY STOCK FEATURED ON O22’S SITE OR NEWSLETTER UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING O22’S SERVICES, JOINING O22’S SITE OR EMAIL/BLOG LIST, OR FOLLOWING ANY SOCIAL NETWORKING PLATFORMS O22 MAY USE.
PLEASE NOTE WELL: O22 IS NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER. O22 IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES AND EXCHANGE COMMISSION, OR FINRA. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED.
THE INFORMATION CONTAINED HEREIN IS BASED ON INFORMATION SUPPLIED BY THE COMPANIES PROFILED, PUBLICLY AVAILABLE INFORMATION, PRESS RELEASES, AND OTHER SOURCES WHICH O22 BELIEVES TO BE RELIABLE, BUT IS NOT GUARANTEED BY O22 AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. O22 IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES PROFILED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE/NEWSLETTER IN DECIDING TO INVEST OR MAKE OTHER FINANCIAL DECISIONS. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE/NEWSLETTER AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. O22 STRONGLY ENCOURAGES READERS AND INVESTORS TO CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES, INCLUDING BY REVIEWING SEC FILINGS (FORMS 10-Q, 10-K, 8-K, 3, 4, 5, SCHEDULE 13D) AND BY CONSULTING YOUR OWN TAX, BUSINESS, FINANCIAL, AND INVESTMENT ADVISORS.
THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT, AND MAY BE FORWARD-LOOKING STATEMENTS. FORWARD-LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD-LOOKING STATEMENTS MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEES, EXPECTS, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, MAY, COULD, OR MIGHT. THERE IS NO GUARANTEE THAT PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS.